Related Experiment Videos
Local binding with globally distributed changes in a small protease inhibitor upon enzyme binding
Zoltán Gáspári1, Borbála Szenthe, András Patthy
1Institute of Chemistry, Eötvös Loránd University, Budapest, Hungary.
The FEBS Journal
|April 21, 2006
Summary
Schistocerca gregaria chymotrypsin inhibitor (SGCI) binds bovine chymotrypsin, showing unexpected effects beyond the binding loop. This suggests the classical inhibitor model may not apply to the pacifastin inhibitor family.
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Biophysics
Background:
- Serine protease inhibitors are crucial regulators of biological processes.
- The pacifastin inhibitor family, including SGCI, plays a role in insect immunity.
- Understanding inhibitor-enzyme interactions is key to drug development.
Purpose of the Study:
- To investigate the complexation of SGCI with bovine chymotrypsin using NMR spectroscopy.
- To elucidate the structural and dynamic changes in SGCI upon binding to chymotrypsin.
- To challenge the classical 'scaffold + binding loop' model for serine protease inhibitors.
Main Methods:
- Nuclear Magnetic Resonance (NMR) spectroscopy, specifically (1)H-(15)N HSQC.
- Titration of SGCI with increasing amounts of bovine chymotrypsin.
- Analysis of chemical shift perturbations and dynamic changes.
Main Results:
- Demonstrated tight and specific binding between SGCI and bovine chymotrypsin.
- Observed significant structural and dynamic changes in SGCI, extending beyond the canonical binding loop.
- Identified retention of some dynamic features of the free inhibitor in the complex.
- Concluded that minor structural transitions explain most, but not all, observed chemical shift changes.
Conclusions:
- The classical 'scaffold + binding loop' model may be insufficient for describing pacifastin inhibitor interactions.
- SGCI's interaction with chymotrypsin involves long-range effects, suggesting a more complex binding mechanism.
- This unique binding mode could explain the evolution of both specific and non-specific inhibitors within this family.